Mathai Mammen, Janssen global head of R&D (Rob Tannenbaum, Endpoints News)

Covid-19 roundup: Study shows J&J's shot is much less ef­fec­tive against Delta vari­ant; No­var­tis open to man­u­fac­tur­ing oth­er coro­n­avirus vac­cines — re­port

As the Delta vari­ant rapid­ly spreads across the US — ac­count­ing for 83% of the coun­try’s cas­es, CDC di­rec­tor Rochelle Walen­sky said yes­ter­day — a new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA